Clinical Trials on Recurrent Angioimmunoblastic T-Cell Lymphoma
Total 8740 results
-
Rhizen Pharmaceuticals SAWithdrawnPeripheral T Cell LymphomaUnited States
-
University of BirminghamCelgene; Amgen; BloodwiseCompletedPeripheral T Cell LymphomaUnited Kingdom
-
National Cancer Centre, SingaporeBristol-Myers SquibbWithdrawnNK/T Cell LymphomaSingapore
-
Mingzhi ZhangUnknownNK/T-Cell LymphomaChina
-
Mingzhi ZhangUnknownNK/T Cell LymphomaChina
-
Ruijin HospitalUnknownPeripheral T Cell LymphomaChina
-
Adam LernerNovartisTerminated
-
Janssen Research & Development, LLCCompletedLymphoma, T-Cell, CutaneousFrance, United Kingdom, Spain, Portugal, United States, Germany
-
Guangdong Provincial People's HospitalUnknown
-
M.D. Anderson Cancer CenterGalderma R&DCompleted
-
The Lymphoma Academic Research OrganisationCompletedPeripheral T Cell LymphomaFrance
-
Eisai Inc.WithdrawnPeripheral T-Cell LymphomaUnited States
-
University of GöttingenCompletedPeripheral T-Cell Lymphoma
-
Chonnam National University HospitalKyungpook National University HospitalUnknownPeripheral T Cell LymphomaKorea, Republic of
-
Samsung Medical CenterAsan Medical Center; Yonsei University; Seoul National University; Chonnam National...CompletedExtranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeKorea, Republic of
-
Peking University First HospitalPeking University Third Hospital; Peking University Cancer Hospital & InstituteRecruitingCutaneous T Cell Lymphoma | Cutaneous T-Cell Lymphoma/Mycosis FungoidesChina
-
OncoSec Medical IncorporatedTerminatedMycosis Fungoides (MF) | Cutaneous T Cell Lymphomas (CTCL)United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Burkitt Lymphoma | Secondary... and other conditionsUnited States
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Acrotech Biopharma Inc.RecruitingPeripheral T Cell LymphomaUnited States
-
Zhao WeiliNot yet recruiting
-
Ruijin HospitalRenJi Hospital; West China Hospital; Shandong Provincial Hospital; Tianjin Medical... and other collaboratorsRecruitingPeripheral T Cell LymphomaChina
-
Second Affiliated Hospital, School of Medicine,...Ningbo No. 1 Hospital; Jinhua Central Hospital; Huizhou Municipal Central HospitalRecruiting
-
Shanghai Zhongshan HospitalTakeda; BeiGeneNot yet recruiting
-
Henan Cancer HospitalRecruitingPeripheral T-Cell LymphomaChina
-
Peking UniversityPeking University Cancer Hospital & InstituteNot yet recruitingNK/T Cell LymphomaChina
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingRefractory T-Cell Lymphoma | T Cell Lymphoma in RelapseChina
-
Genor Biopharma Co., Ltd.RecruitingPeripheral T Cell LymphomaChina
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaFrance, United Kingdom, Netherlands, Denmark, Italy, Spain
-
Antengene CorporationActive, not recruitingPeripheral T-cell Lymphoma | NK/T-cell LymphomaChina
-
Innate PharmaCompletedPeripheral T Cell LymphomaKorea, Republic of, United States
-
University of Colorado, DenverBristol-Myers SquibbActive, not recruitingPeripheral T Cell LymphomaUnited States
-
Innate PharmaCompletedCutaneous T-Cell LymphomaUnited States, France, Netherlands, United Kingdom
-
Conjupro Biotherapeutics, Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Withdrawn
-
Eli Lilly and CompanyCompletedCutaneous T-Cell LymphomaUnited States
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownPeripheral T Cell Lymphoma
-
Zhejiang Cancer HospitalUnknownPeripheral T Cell LymphomaChina
-
Eisai Co., Ltd.CompletedPeripheral T-Cell LymphomaJapan
-
The University of Hong KongUnknown
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.TerminatedPilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30Peripheral T-Cell LymphomaUnited States
-
Nanfang Hospital of Southern Medical UniversityUnknownPeripheral T Cell LymphomaChina
-
Samsung Medical CenterCompleted
-
NovartisCompletedCutaneous T-Cell Lymphoma | TumorsJapan
-
University Hospital, GrenobleFrench Innovative Leukemia OrganisationCompletedPeripheral T Cell LymphomaFrance
-
Mahidol UniversityBayerTerminatedPeripheral T-Cell LymphomaThailand
-
M.D. Anderson Cancer CenterZiopharm OncologyTerminatedRecurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Refractory B Acute Lymphoblastic Leukemia | Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Refractory... and other conditionsUnited States
-
Joseph TuscanoNational Cancer Institute (NCI); CelgeneActive, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
Peking Union Medical College HospitalUnknownDiffuse Large B Cell Lymphoma | Peripheral T-Cell Lymphoma | Lymphoma,Non-Hodgkin